Back to today’s briefing

Story perspectives

Super Bowl Ad Sparks Controversy Over Weight-Loss Drug

2/11/2025

50 6

Summary

Story summary

During Super Bowl LIX, Hims & Hers stirred up controversy with an ad for its weight-loss drug, semaglutide, positioning it as a budget-friendly alternative to Wegovy. This bold move drew sharp criticism from U.S. senators who questioned the drug's safety and the ad's messaging, spotlighting the urgent need for affordable healthcare in the costly weight-loss market.

1 of 1

Story summary

During Super Bowl LIX, Hims & Hers stirred up controversy with an ad for its weight-loss drug, semaglutide, positioning it as a budget-friendly alternative to Wegovy. This bold move drew sharp criticism from U.S. senators who questioned the drug's safety and the ad's messaging, spotlighting the urgent need for affordable healthcare in the costly weight-loss market.